findmyKOL

Nicholas Maragakis, MD

Enriched profile

Professor of Neurology, Johns Hopkins University School of Medicine; Director, Center for ALS Specialty Care; Director, ALS Center for Cell Therapy and Regeneration Research; Medical Director, ALS Clinical Trials Unit · Johns Hopkins University

ORCIDNPI
Region🇺🇸 Baltimore, MD · Northeast · United StatesSpecialtyNeurologyFocusAmyotrophic Lateral Sclerosis Research+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2023NIH funding1999–2024

Nicholas Maragakis is Professor of Neurology, Johns Hopkins University School of Medicine; Director, Center for ALS Specialty Care; Director, ALS Center for Cell Therapy and Regeneration Research; Medical Director, ALS Clinical Trials Unit at Johns Hopkins University. OpenAlex indexes 185 publications with 11,701 citations (h-index 56); ClinicalTrials.gov lists 5 registered studies with this person as an investigator.

Data verified 14 Aug 2026

Overview

Updated 1 Sept 2026

Nicholas Maragakis, M.D., is Professor of Neurology, Johns Hopkins University School of Medicine. The public record shows 185 publications with 11,701 citations (h-index 56), centered on Amyotrophic Lateral Sclerosis Research, Neurogenetic and Muscular Disorders Research, Parkinson's Disease Mechanisms and Treatments. It also documents an investigator role on 5 registered clinical trials, industry payments reported by 3 companies, 4 NIH-funded awards (1999–2024).

  • Most recent indexed publication: 2026 · Annals of neurology
  • Top research focus: Amyotrophic Lateral Sclerosis Research
  • 5 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 3 companies

Generated from the cited public record · current as of 1 Sept 2026. Every fact links its source below.

Indications focus

from trials led + research topics
ALS4 trialsMotor Neuron Disease4 trialsMuscular Atrophy1 trialMuscular Atrophy, Spinal1 trialAtrophy1 trialAmyotrophy, monomelic1 trialParkinson's Disease

Research focus

OpenAlex concept fingerprint
Amyotrophic Lateral Sclerosis ResearchNeurogenetic and Muscular Disorders ResearchParkinson's Disease Mechanisms and TreatmentsNeurogenesis and neuroplasticity mechanismsPluripotent Stem Cells Research

Drugs & molecules

across trials, industry payments and publications
Non-Covered ProductClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
Apellis Pharmaceuticals, Inc.Clinical trialsIndustry payments3Johns Hopkins UniversityClinical trials3Industry paymentsSt. Joseph's Hospital and Medical Center, PhoenixClinical trials2Industry payments

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
185publications

Distinct works indexed by OpenAlex, matched via ORCID; 16 in PubMed.

11,701citations

Total citations across indexed works.

56h-index

Hirsch index (OpenAlex). i10-index 110.

Clinical & industry

trials, payments and federal funding
5clinical trials

Investigator role on registered studies.

View trials
3companies · 2021–2023

Companies reporting payments to CMS. Facts, not judgments.

View payments
4NIH grants · 1999–2024

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 1 Sept 2026

Listed as an investigator on 5 registered studies on ClinicalTrials.gov. The most recent:

2 more trial records behind the reveal.Reveal →

Industry payments

Updated 1 Sept 2026

3 companies reported payments to CMS in program years 2021–2023. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Nervous system

    81.4%
    Benzothiazole81.4%
    Riluzole100%
    Part D23 patients
  • Musculoskeletal

    9.3%
    gamma-Aminobutyric Acid-ergic Agonist9.3%
    Baclofen100%
    Part D<11 patients
  • Respiratory

    9.3%
    Anticholinergic9.3%
    Glycopyrrolate100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 1 Sept 2026

4 NIH research awards on record, funded 19992024 per NIH RePORTER. The latest:

Publications

Updated 1 Sept 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 1 Sept 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 1 Sept 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/nicholas-maragakis-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/nicholas-maragakis-337b28251

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • ResearchGate

    researchgate.net/profile/Nicholas-Maragakis

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net

Mentions by others

where others cite or feature them
  • Other

    neals.org/about/leadership/nicholas-j-maragakis-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →neals.org
  • Other

    answerals.org/team-member/nicholas-maragakis-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →answerals.org
  • Other

    hopkinsmedicine.org/neurology-neurosurgery/clinical-trials/als-clinical-trials/team

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hopkinsmedicine.org
2 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 1 Sept 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record

Editorial & leadership roles

journal and society appointments
  • Leadership

    Northeast ALS Consortium (NEALS)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →neals.org
  • Member

    American Academy of Neurology

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com

Secondary affiliations

appointments beyond the home institution

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.